Science|Business Reporting

European cell therapy pioneer makes further advance

This week TiGenix reported positive safety data for its stem cell therapy for rheumatoid arthritis. The news highlights the potential of regenerative medicine as Science|Business publishes a special report examining how Europe can build on its leading position in this fast-paced field of research

The next step: Mixing biofuels with fossil fuels

Interview with Professor David Zilberman, professor of agricultural and resource economics at the University of California, Berkeley and principal investigator at the UC Berkeley Energy Biosciences Institute